Paul Tudor Jones Vera Therapeutics, Inc. Transaction History
Tudor Investment Corp Et Al
- $29 Billion
- Q1 2025
A detailed history of Paul Tudor Jones (Tudor Investment Corp Et Al) transactions in Vera Therapeutics, Inc. stock. As of the latest transaction made, Tudor Investment Corp Et Al holds 46,063 shares of VERA stock, worth $963,177. This represents 0.0% of its overall portfolio holdings.
Number of Shares
46,063
Previous 31,843
44.66%
Holding current value
$963,177
Previous $1.35 Million
17.83%
% of portfolio
0.0%
Previous 0.01%
Shares
4 transactions
Others Institutions Holding VERA
# of Institutions
196Shares Held
63.9MCall Options Held
723KPut Options Held
186K-
Avoro Capital Advisors LLC New York, NY5.7MShares$119 Million2.22% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD4.75MShares$99.4 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.34MShares$69.8 Million0.0% of portfolio
-
Abingworth LLP London, X02.96MShares$61.9 Million19.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.92MShares$61 Million0.0% of portfolio
About Vera Therapeutics, Inc.
- Ticker VERA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 27,042,300
- Market Cap $565M
- Description
- Vera Therapeutics, Inc., a clinical stage biotechnology company, focuses on developing and commercializing treatments for patients with serious immunological diseases in the United States. Its lead product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection that is in Phase IIb clinical trial for patients with ...